Logo image of LAWS

LAWSON PRODUCTS INC (LAWS) Stock Fundamental Analysis

NASDAQ:LAWS - Nasdaq - US5207761058 - Common Stock

40.42  -0.73 (-1.77%)

After market: 40.42 0 (0%)

Fundamental Rating

3

Taking everything into account, LAWS scores 3 out of 10 in our fundamental rating. LAWS was compared to 49 industry peers in the Trading Companies & Distributors industry. LAWS may be in some trouble as it scores bad on both profitability and health. LAWS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year LAWS was profitable.
LAWS Yearly Net Income VS EBIT VS OCF VS FCFLAWS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 10M 20M 30M

1.2 Ratios

Industry RankSector Rank
ROA 5.47%
ROE 10.37%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LAWS Yearly ROA, ROE, ROICLAWS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 10 20 30

1.3 Margins

Industry RankSector Rank
OM 5.15%
PM (TTM) 3.42%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LAWS Yearly Profit, Operating, Gross MarginsLAWS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 40 60

3

2. Health

2.1 Basic Checks

LAWS has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for LAWS is higher compared to a year ago.
LAWS Yearly Shares OutstandingLAWS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M
LAWS Yearly Total Debt VS Total AssetsLAWS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M

2.2 Solvency

LAWS has an Altman-Z score of 6.47. This indicates that LAWS is financially healthy and has little risk of bankruptcy at the moment.
LAWS has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 6.47
ROIC/WACCN/A
WACCN/A
LAWS Yearly LT Debt VS Equity VS FCFLAWS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M 40M 60M 80M 100M

2.3 Liquidity

LAWS has a Current Ratio of 2.05. This indicates that LAWS is financially healthy and has no problem in meeting its short term obligations.
LAWS has a Quick Ratio of 2.05. This is a bad value and indicates that LAWS is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.05
Quick Ratio 0.97
LAWS Yearly Current Assets VS Current LiabilitesLAWS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M

6

3. Growth

3.1 Past

LAWS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 152.87%, which is quite impressive.
LAWS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 153.17% yearly.
Looking at the last year, LAWS shows a quite strong growth in Revenue. The Revenue has grown by 18.66% in the last year.
Measured over the past years, LAWS shows a quite strong growth in Revenue. The Revenue has been growing by 8.59% on average per year.
EPS 1Y (TTM)152.87%
EPS 3Y16.37%
EPS 5Y153.17%
EPS Q2Q%26.67%
Revenue 1Y (TTM)18.66%
Revenue growth 3Y6.11%
Revenue growth 5Y8.59%
Sales Q2Q%13.78%

3.2 Future

The Earnings Per Share is expected to grow by 15.95% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.99% on average over the next years.
EPS Next Y23.33%
EPS Next 2Y19.87%
EPS Next 3Y16.86%
EPS Next 5Y15.95%
Revenue Next Year6.61%
Revenue Next 2Y5.51%
Revenue Next 3Y4.81%
Revenue Next 5Y4.99%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LAWS Yearly Revenue VS EstimatesLAWS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
LAWS Yearly EPS VS EstimatesLAWS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.37, which indicates a rather expensive current valuation of LAWS.
Compared to an average S&P500 Price/Earnings ratio of 25.05, LAWS is valued a bit cheaper.
A Price/Forward Earnings ratio of 13.52 indicates a correct valuation of LAWS.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.07, LAWS is valued a bit cheaper.
Industry RankSector Rank
PE 18.37
Fwd PE 13.52
LAWS Price Earnings VS Forward Price EarningsLAWS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 25.87
LAWS Per share dataLAWS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LAWS's earnings are expected to grow with 16.86% in the coming years.
PEG (NY)0.79
PEG (5Y)0.12
EPS Next 2Y19.87%
EPS Next 3Y16.86%

0

5. Dividend

5.1 Amount

No dividends for LAWS!.
Industry RankSector Rank
Dividend Yield N/A

LAWSON PRODUCTS INC

NASDAQ:LAWS (5/6/2022, 8:00:03 PM)

After market: 40.42 0 (0%)

40.42

-0.73 (-1.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)04-28 2022-04-28/bmo
Earnings (Next)07-27 2022-07-27
Inst Owners223.21%
Inst Owner Change-0.86%
Ins Owners63.31%
Ins Owner Change0%
Market Cap784.96M
Analysts82.5
Price Target62.22 (53.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.37
Fwd PE 13.52
P/S 1.82
P/FCF N/A
P/OCF N/A
P/B 5.5
P/tB N/A
EV/EBITDA 25.87
EPS(TTM)2.2
EY5.44%
EPS(NY)2.99
Fwd EY7.39%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS22.25
BVpS7.35
TBVpSN/A
PEG (NY)0.79
PEG (5Y)0.12
Profitability
Industry RankSector Rank
ROA 5.47%
ROE 10.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 5.15%
PM (TTM) 3.42%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.6
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.05
Quick Ratio 0.97
Altman-Z 6.47
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152.87%
EPS 3Y16.37%
EPS 5Y153.17%
EPS Q2Q%26.67%
EPS Next Y23.33%
EPS Next 2Y19.87%
EPS Next 3Y16.86%
EPS Next 5Y15.95%
Revenue 1Y (TTM)18.66%
Revenue growth 3Y6.11%
Revenue growth 5Y8.59%
Sales Q2Q%13.78%
Revenue Next Year6.61%
Revenue Next 2Y5.51%
Revenue Next 3Y4.81%
Revenue Next 5Y4.99%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A